Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about CSLLY

Recent news which mentions CSLLY

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Tickers ABBV CSLLY GILD GSK
Tags Wall Street's Most Accurate Analysts Analyst Ratings Market News
From Benzinga
GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine Production: Report
Tickers CSLLY GSK NEWS SNY
Tags Health Care GSK Large Cap
From Benzinga
Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's Comirnaty Shot, Even At Lower Doses
Tickers ARCT CSLLY NEWS PFE
Tags ARCT Market News Large Cap
From Benzinga
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
Tickers CSLLY NEWS PFE
Tags FDA General Biotech
From Benzinga
Arcturus Therapeutics' Lung Disease Candidate Triggers Bullish Rating, Analyst Sees Over 200% Upside
Tickers ARCT CSLLY
Tags Analyst Color Markets ARCT
From Benzinga
Credit Suisse's $17B Of AT1 Debt Written Down To Zero, Richard Branson's Virgin Orbit Plans Insolvency, Court Freezes Volkswagen's Russian Assets: Today's Top Stories
Tickers BBBY CS CSLLY EADSF
Tags BBBY Biotech Benzinga
From Benzinga
Large Vaccine Players Including GSK, Moderna Prepare For Bird Flu Vaccine 'Just In Case'
Tickers CSLLY GSK MRNA SNY
Tags Briefs Large Cap CSLLY
From Benzinga
Travere Therapeutics Scores Accelerated FDA Approval For Rare Kidney Disease Treatment
Tickers CSLLY LGND TVTX
Tags Benzinga Biotech Movers
From Benzinga
FDA Approves UniQure's Hemgenix, First Hemophilia B Gene Therapy For Adults
Tickers BLUE CSLLY QURE
Tags Benzinga Biotech Briefs
From Benzinga
Why Is Arcturus Therapeutics (ARCT) Stock Up 30% Today?
Tickers ARCT CSLLY
Tags Today's Market CSLLY NASDAQ:ARCT,OTCMKTS:CSLLY
From InvestorPlace
Arcturus Shares Jump After Collaboration With CSL For mRNA-Based Vaccines
Tickers ARCT CSLLY
Tags Briefs premarket trading Movers
From Benzinga
Travere, CSL's Sparsentan Application Is Under European Review For Rare Kidney Disorder
Tickers CSLLY TVTX
Tags News TVTX CSLLY
From Benzinga
CSL Posts Encouraging Data From Garadacimab In Severe Swelling Attacks
Tickers CSLLY
Tags News CSLLY Briefs
From Benzinga
The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product
Tickers BBIO BFRI BMY BTTX
Tags BTTX Movers STAB
From Benzinga
CSL Seals $11.7B Buyout Deal Of Vifor Pharma, Probably the Largest Healthcare Deal In 2021
Tickers CSLLY GNHAF GNHAY MRK
Tags News CSLLY GNHAY
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS